Top compounds associated with response to ETFDH


Feature Type Standardized
Nominal ANOVA
mRNA 16-beta-bromoandrosterone CTRPv2 pan-cancer AAC 0.17 2e-05
mRNA Dasatinib CTRPv2 pan-cancer AAC -0.16 3e-05
mRNA oligomycin a CTRPv2 pan-cancer AAC 0.15 4e-05
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.13 0.0002
mRNA bid1870 gCSI pan-cancer AAC -0.22 0.0002
mRNA AZD1480 CTRPv2 pan-cancer AAC 0.19 0.0006
mRNA ELCPK CTRPv2 pan-cancer AAC 0.18 0.0007
mRNA GSK1120212 CTRPv2 pan-cancer AAC -0.17 0.0007
mRNA MK-2206 CTRPv2 pan-cancer AAC 0.13 0.0008
mRNA SRT-1720 CTRPv2 pan-cancer AAC 0.13 0.0008
Download CSV